Human Albumin Administration Guidelines

Primary Indications for Albumin Administration

The American Association for the Study of Liver Diseases recommends administering human albumin at 6-8 g/L of ascites fluid removed for large-volume paracentesis (>5L) to reduce the risk of paracentesis-induced circulatory dysfunction (PICD) by 61% compared to alternative treatments 1
The European Association for the Study of the Liver suggests that for patients with low-severity cirrhosis, a half dose (4 g/L) of human albumin may be effective and safe 2
Human albumin should be administered slowly to prevent cardiac overload, especially in patients with preexisting cardiomyopathy, as recommended by the American Heart Association 2
The American College of Gastroenterology recommends limiting ascites removal to less than 8 liters during a single paracentesis procedure to reduce PICD risk 2
Human albumin reduces the risk of hyponatremia by 42% and mortality by 36% in patients undergoing large-volume paracentesis, according to the American Association for the Study of Liver Diseases 1

The American College of Chest Physicians recommends against using human albumin for patients with cirrhosis and extraperitoneal infections 4, 5
The Society of Critical Care Medicine suggests that human albumin is not recommended for routine treatment of hypoalbuminemia in decompensated cirrhosis 4, 5

The American Society of Anesthesiologists recommends monitoring for signs of fluid overload, especially in patients with preexisting cardiac conditions, when administering human albumin 2
The National Institute of Diabetes and Digestive and Kidney Diseases suggests assessing volume status, cardiovascular function, and kidney function before administering human albumin 4, 5
The American College of Physicians recommends considering personalized dosing based on baseline creatinine, volume of ascites removed, and history of hypotensive symptoms when administering human albumin 4
The American Thoracic Society suggests being vigilant for pulmonary edema, especially when using higher doses of human albumin for spontaneous bacterial peritonitis (SBP) 4, 5